成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-

1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)- Struktur
2417798-14-0
CAS-Nr.
2417798-14-0
Englisch Name:
1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
Synonyma:
Ticagrelor Impurity 173;Ticagrelor IP impurity DQ: What is Ticagrelor IP impurity D Q: What is the CAS Number of Ticagrelor IP impurity D;(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-((R)-propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
CBNumber:
CB48220123
Summenformel:
C23H28F2N6O5S
Molgewicht:
538.57
MOL-Datei:
2417798-14-0.mol

1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)- Eigenschaften

Siedepunkt:
821.3±75.0 °C(Predicted)
Dichte
1.75±0.1 g/cm3(Predicted)
pka
13.25±0.70(Predicted)

Sicherheit

1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Ticagrelor Sulfoxide is an impurity of Ticagrelor(T437700); Ticagrelor is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).

1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11922 58
Moxin Chemicals 		+8617320513646
 mike@molcoo.com China 9457 58
QUALITY CONTROL SOLUTIONS LTD. 		0755-66853366; 13670046396
 ORDERS@QCSRM.COM China 24342 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
 greensnown@163.com China 9906 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 8705 55
Molcoo Chemicals Inc. 18576690171 17386083646
 3001006472@qq.com China 11837 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954
 tianwen.zhan@cato-chem.com China 7735 58
guoyungurui 18162595016; 18162595016
 3287908757@qq.com China 10335 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 13217415044 13217415044
 2851922763@qq.com China 7939 58
Hubei Moco Chemical Co., Ltd. 18627753421 18627756402
 3001009495@qq.com China 19063 58
  • 1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[(R)-propylsulfinyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
  • Ticagrelor IP impurity DQ: What is Ticagrelor IP impurity D Q: What is the CAS Number of Ticagrelor IP impurity D
  • (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-((R)-propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • Ticagrelor Impurity 173
  • 2417798-14-0
Copyright 2019 ? ChemicalBook. All rights reserved